Today: 27 April 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Shell share price rises as buyback end nears and Venezuela gas licenses come into view

Shell share price rises as buyback end nears and Venezuela gas licenses come into view

Shell shares gained 0.9% to 2,757.5 pence in early London trading Thursday as its $3.5 billion buyback neared completion ahead of fourth-quarter results. The company bought over 1 million shares across London and Amsterdam on Jan. 28 for cancellation. Brent crude closed at $68.40 a barrel Wednesday, its highest since September. Shell faces a legal fight in New York over an arbitration loss to Venture Global.
29 January 2026
··
Lloyds share price edges up after profit beat, bigger buyback and fresh 2026 targets

Lloyds share price edges up after profit beat, bigger buyback and fresh 2026 targets

Lloyds Banking Group shares rose 0.6% after the bank beat profit forecasts, raised its outlook, and announced a £1.75 billion share buyback. The lender set aside £968 million for motor finance remediation, warning this will impact full-year results. The board raised the final dividend to 2.43 pence per share. Return on tangible equity reached 12.9%, or 14.8% excluding the motor finance charge.
29 January 2026
·
Compass Group share price slips: what traders watch before the Feb. 5 update

Compass Group share price slips: what traders watch before the Feb. 5 update

Compass Group shares slipped 0.2% to 2,194 pence in early London trading Thursday, after closing at 2,198. Around 109,000 shares changed hands as investors awaited a company update at the annual general meeting set for 10:30 a.m. The stock’s 52-week range stands between 2,167 and 2,853 pence. The FTSE 100 fell 0.5% Wednesday amid shifting rate expectations and a U.S. tech rally.
29 January 2026
·
GSK shares tick higher after Citi’s neutral call as Feb. 4 results loom

GSK shares tick higher after Citi’s neutral call as Feb. 4 results loom

GSK shares rose 0.34% to 1,823.75 pence early Thursday in London after a 2.42% drop Wednesday. Citi began coverage with a Neutral rating and a 1,900p target, noting pipeline improvements but warning on valuation. Investors await GSK’s Feb. 4 earnings for updates on vaccines, HIV treatments, and 2026 guidance. GSK’s RSV vaccine Arexvy recently gained EU approval for adults 18 and older.
29 January 2026
··
Anglo American share price jumps as copper hits record highs; what investors watch next

Anglo American share price jumps as copper hits record highs; what investors watch next

Anglo American shares rose 4.1% to 3,618 pence in early London trading Thursday after copper prices hit a record high, with the LME benchmark contract jumping 6.3% to $13,913.50 a ton. Glencore reported an 11% drop in 2025 copper output, citing lower grades and water shortages at the Collahuasi mine. Anglo American will release its Q4 production report on Feb. 5.
29 January 2026
···
LSEG share price nudges higher after buyback notice as London trading kicks off

LSEG share price nudges higher after buyback notice as London trading kicks off

London Stock Exchange Group shares rose 0.1% to 8,304 pence in early trading Thursday after announcing the purchase and planned cancellation of 209,783 shares on Jan. 28. The buyback follows a program launched in November. Investors are awaiting LSEG’s preliminary results due Feb. 26. The FTSE 100 slipped 0.5% Wednesday amid cautious sentiment after the U.S. Federal Reserve held rates steady.
29 January 2026
·
Imperial Brands share price slips as buyback rolls on; AGM clears dividend

Imperial Brands share price slips as buyback rolls on; AGM clears dividend

Imperial Brands shares slipped 0.3% to 3,019p in early London trading Thursday after announcing further share buybacks for cancellation. The company repurchased 289,199 shares Wednesday and 195,136 shares Tuesday, both via Morgan Stanley. Shareholders approved all AGM resolutions, including the final dividend. The stock goes ex-dividend Feb. 19, with payment due March 31.
29 January 2026
···
Rolls-Royce share price in focus: Delta Airbus order and buyback filing tee up London open

Rolls-Royce share price in focus: Delta Airbus order and buyback filing tee up London open

Rolls-Royce shares fell 2.6% Wednesday to £12.08, underperforming the FTSE 100. Delta Air Lines ordered 31 Airbus widebodies powered by Rolls-Royce Trent engines, with deliveries from 2029. Rolls-Royce repurchased 845,685 shares on Jan. 28 as part of its £200 million buyback. CEO Tufan Erginbilgic and CFO Helen McCabe sold shares to cover tax after incentive plan vesting.
29 January 2026
···
ABB Q4 earnings spark $2 billion buyback as orders surge; 2026 outlook targets up to 9% growth

ABB Q4 earnings spark $2 billion buyback as orders surge; 2026 outlook targets up to 9% growth

ABB launched a $2 billion share buyback and proposed raising its dividend after Q4 orders jumped 36% to $10.3 billion. Revenue rose 13% to $9.05 billion, with operational EBITA up 19% to $1.59 billion, beating analyst forecasts. The company expects 7%-10% comparable revenue growth in Q1 and 6%-9% for 2026. ABB’s robotics division was excluded from results as it is being sold.
29 January 2026
··
Seatrium share price slips on SGX as Feb 26 results loom, DolWin 5 arbitration in focus

Seatrium share price slips on SGX as Feb 26 results loom, DolWin 5 arbitration in focus

Seatrium shares slipped 0.5% to S$2.11 in Thursday afternoon trading, ahead of its Feb. 26 full-year results. The company remains locked in arbitration with Aibel over the DolWin 5 project, with claims totaling nearly 300 million euros. Both parties say any valid claims should be covered by existing consortium funds. The arbitration’s financial impact remains uncertain.
29 January 2026
·
1 … 125 126 127 128 129 … 584

Stock Market Today

  • Structure Therapeutics (GPCR) Valuation Falters Amid Share Price Decline
    April 26, 2026, 10:46 PM EDT. Structure Therapeutics (GPCR) shares dropped to $45.49, marking a 49.21% decline over 90 days despite a strong 91.62% one-year total return. The biotech's price-to-book (P/B) ratio of 2.1x appears undervalued versus peers' average of 31.2x and the US pharmaceuticals sector average of 2.6x, suggesting cautious investor sentiment. This ratio compares market value to book value, often used for early-stage or loss-making companies. GPCR faces risks from ongoing clinical trials for GSBR-1290 and significant net losses of $141.2 million. Analyst forecasts predict 56.5% annual revenue growth, but uncertainties linger. Investors should balance potential gains with risks, monitoring clinical outcomes and funding capabilities amid a volatile healthcare sector.

Latest article

Kratos Defense Stock Slides Again as Drone Maker’s $1 Billion Growth Bet Faces Test

Kratos Defense Stock Slides Again as Drone Maker’s $1 Billion Growth Bet Faces Test

26 April 2026
Kratos Defense shares dropped 6.5% to $61.26, cutting its market value to $10.6 billion as investors questioned the pace of profit from new contracts. The company recently completed the first flight of its Mk1 Firejet drone and won a Space Force contract worth up to $446.8 million. AeroVironment, L3Harris, and Northrop Grumman also declined. Kratos raised $1.17 billion in a February share offering.
Robinhood’s Earnings Week Now Has a Prediction-Market Problem

Robinhood’s Earnings Week Now Has a Prediction-Market Problem

26 April 2026
Wisconsin sued Robinhood and several rivals over sports event contracts, alleging illegal sports betting through prediction markets. The lawsuit comes days before Robinhood reports first-quarter earnings on Tuesday. Robinhood shares closed at $84.71 Friday, down from $91.28 on Monday. The company said its event contracts are federally regulated and it will defend itself.
SoFi Technologies Stock Faces a Big Q1 Earnings Test as Loan Growth Comes Into Focus

SoFi Technologies Stock Faces a Big Q1 Earnings Test as Loan Growth Comes Into Focus

26 April 2026
SoFi will report first-quarter results before markets open April 29, with management projecting about $1.04 billion in adjusted net revenue and adjusted EPS of 12 cents. Shares closed at $18.44 Friday, valuing the company at $23.8 billion. The company recently launched a digital HELOC and formed a Real Estate Advisory Council. Last quarter, loan originations rose 46% to $10.5 billion and fee-based revenue climbed 53%.
Go toTop